Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs Limited has submitted to BSE and NSE a quarterly compliance certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, for the quarter ended December 31, 2025. The certificate confirms that all securities received from depository participants for dematerialization during the quarter were processed (accepted or rejected) within the timelines prescribed under SEBI rules. It also confirms that physical share certificates received were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's register of members. Importantly, the RTA noted that no requests for dematerialization were received from shareholders during the quarter, indicating routine, low activity on this front. The filing is purely a regulatory compliance submission and not tied to any corporate action or event.
This is a routine quarterly compliance filing with no material impact on the business, operations, or shareholders. It carries no signal for stock price movement and is purely administrative in nature.